The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease

NCT04206176 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2020-05-21

No results posted yet for this study

Summary

This study aims to assess the effects of low dose ticagrelor on platelet function testing in patients with stable coronary artery disease.

Conditions

  • Platelet Dysfunction Due to Drugs

Interventions

DRUG

Ticagrelor

Ticagrelor 45mg twice daily per oral administration

Sponsors & Collaborators

  • The University of The West Indies

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-03-31
Completion
2020-03-31
FDA Drug
Yes

Countries

  • Trinidad and Tobago

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04206176 on ClinicalTrials.gov